← Eichor
Study identifier: NCT06363604 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of PWI Assisted by Marshall Ethanolization in Ablation of Persistent Atrial Fibrillation

Condition: Atrial Fibrillation  ·  Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

PhaseNA
Planned participants260
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersYes

About this study

This is a prospective, randomized controlled, single-blind, multi-center clinical trial study aiming to investigate whether the strategy of posterior wall isolation (PWI) assisted by vein of Marshall ethanol infusion (VOMEI) could improve the success rate of persistent atrial fibrillation ablation.

This description comes directly from the study's public registry record.

Talk to the study team

Yichi YU, Dr.  ·  +8613585563975  ·  yuyichi@xinhuamed.com.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Xinhua Hospital, Shanghai Jiao Tong UniversityShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06363604